Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletionKohno, S.; Linn, P.; Nagatani, N.; Watanabe, Y.; Kumar, S.; Soga, T.; Takahashi, C.
2012Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressorMori, S.; Bernardi, R.; Laurent, A.; Resnati, M.; Crippa, A.; Gabrieli, A.; Keough, R.; Gonda, T.; Blasi, F.; Plow, E.
2019Alpha-Blockers as colorectal cancer chemopreventive: findings from a case-control study, human cell cultures, and in vivo preclinical testingSuzuki, N.; Niikura, R.; Ihara, S.; Hikiba, Y.; Kinoshita, H.; Higashishima, N.; Hayakawa, Y.; Yamada, A.; Hirata, Y.; Nakata, R.; Okamoto, M.; Sano, M.; Kushiyama, A.; Ichinose, M.; Woods, S.L.; Worthley, D.; Iwamoto, Y.; Koike, K.
2005Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cellsNeufing, P.; Clancy, R.; Jackson, M.; Tran, H.; Buyon, J.; Gordon, T.
2002Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9O'Reilly, L.; Ekert, P.; Harvey, N.; Marsden, V.; Cullen, L.; Vaux, D.; Hacker, G.; Magnusson, C.; Pakusch, M.; Cecconi, F.; Kuida, K.; Strasser, A.; Huang, D.; Kumar, S.
2002Flt3 ligand expands dendritic cell numbers in normal and malignant murine prostateMoghaddami, M.; Swart, B.; Reynolds, P.; Diener, K.; Brown, M.
2007Imatinib increases the intracellular concentration of nilotinib which may explain the observed synergy between these drugsWhite, D.; Saunders, V.; Quinn, S.; Manley, P.; Hughes, T.